Loading clinical trials...
Loading clinical trials...
This is a multicenter prospective observational study lead by the FIL on sarcopenia and sGA as possible predictors of efficacy and toxicity outcomes in patients undergoing CAR-T cells treatment.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fondazione Italiana Linfomi - ETS
Collaborators
NCT05909059 · Non-hodgkin Lymphoma,B Cell, Multiple Myeloma, and more
NCT05741359 · Non-hodgkin Lymphoma,B Cell
NCT06838832 · Non-hodgkin Lymphoma,B Cell
NCT06160362 · Non-hodgkin Lymphoma,B Cell
NCT05631912 · Non-hodgkin Lymphoma,B Cell
A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C.D.U. Ematologia
Alessandria
AOU Ospedali Riuniti - Clinica di Ematologia
Ancona
Azienda Ospedaliera S .Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico
Avellino
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions